BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 2014;100:145-57. [PMID: 24639412 DOI: 10.1002/bdra.23235] [Cited by in Crossref: 151] [Cited by in F6Publishing: 126] [Article Influence: 18.9] [Reference Citation Analysis]
Number Citing Articles
1 Paes B, Fauroux B, Figueras-Aloy J, Bont L, Checchia PA, Simões EA, Manzoni P, Carbonell-Estrany X. Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease. Infect Dis Ther 2016;5:453-71. [PMID: 27864751 DOI: 10.1007/s40121-016-0137-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
2 Dassios T, Curley A, Krokidis M, Morley C, Ross-Russell R. Correlation of radiographic thoracic area and oxygenation impairment in bronchopulmonary dysplasia. Respir Physiol Neurobiol 2016;220:40-5. [PMID: 26410458 DOI: 10.1016/j.resp.2015.09.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
3 Hagadorn JI, Brownell EA, Trzaski JM, Johnson KR, Lainwala S, Campbell BT, Herbst KW. Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus. Pediatr Res 2016;80:785-92. [DOI: 10.1038/pr.2016.166] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 8.7] [Reference Citation Analysis]
4 Wang X, Fu JH, Xue XD. Expression dynamics of caveolin-1 in fibroblasts of newborn rats with chronic lung disease and its impact on lung fibroblast proliferation. Acta Cir Bras 2017;32:359-68. [PMID: 28591365 DOI: 10.1590/s0102-865020170050000005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Tayman C, Çakır U, Akduman H, Karabulut Ş, Çağlayan M. The therapeutic effect of Apocynin against hyperoxy and Inflammation-Induced lung injury. Int Immunopharmacol 2021;101:108190. [PMID: 34607228 DOI: 10.1016/j.intimp.2021.108190] [Reference Citation Analysis]
6 Jin R, Xu J, Gao Q, Mao X, Yin J, Lu K, Guo Y, Zhang M, Cheng R. IL-33-induced neutrophil extracellular traps degrade fibronectin in a murine model of bronchopulmonary dysplasia. Cell Death Discov 2020;6:33. [PMID: 32377396 DOI: 10.1038/s41420-020-0267-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
7 Mueller M, Kramer BW. Stem cells and Bronchopulmonary Dysplasia - The five questions: Which cells, when, in which dose, to which patients via which route? Paediatr Respir Rev 2017;24:54-9. [PMID: 28162941 DOI: 10.1016/j.prrv.2016.12.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
8 Ottolini KM, Litke-Wager CA, Johnson RL, Schulz EV. Serratia Chorioamnionitis and Culture Proven Sepsis in a Preterm Neonate: A Case Report and Review of the Literature. Pediatr Infect Dis J 2021;40:e62-5. [PMID: 33093431 DOI: 10.1097/INF.0000000000002962] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Stouch AN, McCoy AM, Greer RM, Lakhdari O, Yull FE, Blackwell TS, Hoffman HM, Prince LS. IL-1β and Inflammasome Activity Link Inflammation to Abnormal Fetal Airway Development. J Immunol 2016;196:3411-20. [PMID: 26951798 DOI: 10.4049/jimmunol.1500906] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
10 Morag I, Barkai E, Wazana Y, Elizur A, Levkovitz Stern O, Staretz-Chacham O, Pinchevski-Kadir S, Ofek Shlomai N. Predictors of Developmental and Respiratory Outcomes Among Preterm Infants With Bronchopulmonary Dysplasia. Front Pediatr 2021;9:780518. [PMID: 34912762 DOI: 10.3389/fped.2021.780518] [Reference Citation Analysis]
11 Yuan Y, Yang Y, Lei X, Dong W. Caffeine and Bronchopulmonary Dysplasia: Clinical Benefits and the Mechanisms Involved. Pediatr Pulmonol 2022. [PMID: 35318830 DOI: 10.1002/ppul.25898] [Reference Citation Analysis]
12 Kim YH, Kim KW, Eun HS, Shin JE, Sol IS, Kim SY, Kim YS, Sohn MH, Namgung R. Small for gestational age birth may increase airflow limitation in bronchopulmonary dysplasia. Pediatr Pulmonol 2019;55:346-53. [DOI: 10.1002/ppul.24580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 DeVries LB, Heyne RJ, Ramaciotti C, Brown LS, Jaleel MA, Kapadia VS, Burchfield PJ, Brion LP. Mortality among infants with evolving bronchopulmonary dysplasia increases with major surgery and with pulmonary hypertension. J Perinatol 2017;37:1043-6. [PMID: 28617427 DOI: 10.1038/jp.2017.89] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
14 Dawson SK, D'Andrea LA, Lau R, Lagatta JM. Using a home oxygen weaning protocol and pCO2 to evaluate outcomes for infants with bronchopulmonary dysplasia discharged on home oxygen. Pediatr Pulmonol 2020;55:3293-303. [PMID: 32897654 DOI: 10.1002/ppul.25057] [Reference Citation Analysis]
15 Sucasas Alonso A, Pértega Díaz S, Sáez Soto R, Ávila-Álvarez A. [Epidemiology and risk factors for bronchopulmonary dysplasia in prematures infants born at or less than 32 weeks of gestation]. An Pediatr (Engl Ed) 2021:S1695-4033(21)00153-3. [PMID: 33814331 DOI: 10.1016/j.anpedi.2021.03.002] [Reference Citation Analysis]
16 Yao H, Gong J, Peterson AL, Lu X, Zhang P, Dennery PA. Fatty Acid Oxidation Protects against Hyperoxia-induced Endothelial Cell Apoptosis and Lung Injury in Neonatal Mice. Am J Respir Cell Mol Biol 2019;60:667-77. [PMID: 30571144 DOI: 10.1165/rcmb.2018-0335OC] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 12.5] [Reference Citation Analysis]
17 Kumar KR, Clark DA, Kim EM, Perry JD, Wright K, Thomas SA, Thompson EJ, Greenberg RG, Smith PB, Benjamin DK Jr, Laughon MM, Clark RH, Hornik CP. Association of Atrial Septal Defects and Bronchopulmonary Dysplasia in Premature Infants. J Pediatr 2018;202:56-62.e2. [PMID: 30172431 DOI: 10.1016/j.jpeds.2018.07.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
18 Santema HY, Stolk J, Los M, Stoel BC, Tsonaka R, Merth IT. Prediction of lung function and lung density of young adults who had bronchopulmonary dysplasia. ERJ Open Res 2020;6:00157-2020. [PMID: 33263029 DOI: 10.1183/23120541.00157-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Dassios T, Dassios KG, Dassios G. Functional morphometry for the estimation of the alveolar surface area in prematurely-born infants. Respir Physiol Neurobiol 2018;254:49-54. [PMID: 29719268 DOI: 10.1016/j.resp.2018.04.008] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Kelly EN, Shah VS, Levenbach J, Vincer M, Dasilva O, Shah PS; for the Canadian Neonatal Network and Canadian Neonatal Follow-Up Network Investigators. Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates. The Journal of Maternal-Fetal & Neonatal Medicine 2018;31:2665-72. [DOI: 10.1080/14767058.2017.1350644] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
21 Bouch S, O'Reilly M, Harding R, Sozo F. Neonatal exposure to mild hyperoxia causes persistent increases in oxidative stress and immune cells in the lungs of mice without altering lung structure. Am J Physiol Lung Cell Mol Physiol 2015;309:L488-96. [PMID: 26138645 DOI: 10.1152/ajplung.00359.2014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
22 Mukerji A, Wahab MGA, Mitra S, Mondal T, Paterson D, Beck J, Fusch C. High continuous positive airway pressure in neonates: A physiological study. Pediatr Pulmonol 2019;54:1039-44. [PMID: 30859756 DOI: 10.1002/ppul.24312] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Gallini F, Coppola M, De Rose DU, Maggio L, Arena R, Romano V, Cota F, Ricci D, Romeo DM, Mercuri EM, Vento G. Neurodevelopmental outcomes in very preterm infants: The role of severity of Bronchopulmonary Dysplasia. Early Hum Dev 2021;152:105275. [PMID: 33227635 DOI: 10.1016/j.earlhumdev.2020.105275] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
24 Hysinger EB, Friedman NL, Padula MA, Shinohara RT, Zhang H, Panitch HB, Kawut SM; Children's Hospitals Neonatal Consortium. Tracheobronchomalacia Is Associated with Increased Morbidity in Bronchopulmonary Dysplasia. Ann Am Thorac Soc 2017;14. [PMID: 28622012 DOI: 10.1513/AnnalsATS.201702-178OC] [Cited by in Crossref: 51] [Cited by in F6Publishing: 16] [Article Influence: 10.2] [Reference Citation Analysis]
25 Sherlock LG, Trumpie A, Hernandez-Lagunas L, McKenna S, Fisher S, Bowler R, Wright CJ, Delaney C, Nozik-Grayck E. Redistribution of Extracellular Superoxide Dismutase Causes Neonatal Pulmonary Vascular Remodeling and PH but Protects Against Experimental Bronchopulmonary Dysplasia. Antioxidants (Basel) 2018;7:E42. [PMID: 29538340 DOI: 10.3390/antiox7030042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
26 Zhang H, Lu H, Yu L, Yuan J, Qin S, Li C, Ge RS, Chen H, Ye L. Effects of gestational exposure to perfluorooctane sulfonate on the lung development of offspring rats. Environ Pollut 2021;272:115535. [PMID: 33223333 DOI: 10.1016/j.envpol.2020.115535] [Reference Citation Analysis]
27 Jensen EA. What is bronchopulmonary dysplasia and does caffeine prevent it? Semin Fetal Neonatal Med 2020;25:101176. [PMID: 33168465 DOI: 10.1016/j.siny.2020.101176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Jain A, McNamara PJ. Persistent pulmonary hypertension of the newborn: Advances in diagnosis and treatment. Semin Fetal Neonatal Med 2015;20:262-71. [PMID: 25843770 DOI: 10.1016/j.siny.2015.03.001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 10.3] [Reference Citation Analysis]
29 Bonadies L, Zaramella P, Porzionato A, Perilongo G, Muraca M, Baraldi E. Present and Future of Bronchopulmonary Dysplasia. J Clin Med 2020;9:E1539. [PMID: 32443685 DOI: 10.3390/jcm9051539] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
30 Cheah FC, Lai CH, Tan GC, Swaminathan A, Wong KK, Wong YP, Tan TL. Intrauterine Gardnerella vaginalis Infection Results in Fetal Growth Restriction and Alveolar Septal Hypertrophy in a Rabbit Model. Front Pediatr 2020;8:593802. [PMID: 33553066 DOI: 10.3389/fped.2020.593802] [Reference Citation Analysis]
31 Helmi H, Siddiqui A, Yan Y, Basij M, Hernandez-Andrade E, Gelovani J, Hsu CD, Hassan SS, Mehrmohammadi M. The role of noninvasive diagnostic imaging in monitoring pregnancy and detecting patients at risk for preterm birth: a review of quantitative approaches. J Matern Fetal Neonatal Med 2020;:1-24. [PMID: 32089024 DOI: 10.1080/14767058.2020.1722099] [Reference Citation Analysis]
32 Mitchell I, Paes B, Lanctot K, Chawla R, Chiu A, Mitchell M, Ojah C, Price A, Seigel S, Symington A. Letters to the Editor. Paediatr Child Health 2015;20:463-4. [PMID: 26744560 DOI: 10.1093/pch/20.8.463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Abounahia FF, Abu-Jarir R, Abounahia MF, Al-Badriyeh D, Abushanab D, Abu-Ghalwa M, Mansour A, Kurdi B, Al-Rifai H. Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial. Clin Drug Investig 2019;39:1093-107. [PMID: 31414269 DOI: 10.1007/s40261-019-00834-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Shrestha AK, Menon RT, Yallampalli C, Barrios R, Shivanna B. Adrenomedullin Deficiency Potentiates Lipopolysaccharide-Induced Experimental Bronchopulmonary Dysplasia in Neonatal Mice. Am J Pathol 2021:S0002-9440(21)00385-0. [PMID: 34508690 DOI: 10.1016/j.ajpath.2021.09.001] [Reference Citation Analysis]
35 Lesage F, Jimenez J, Toelen J, Deprest J. Preclinical evaluation of cell-based strategies to prevent or treat bronchopulmonary dysplasia in animal models: a systematic review. J Matern Fetal Neonatal Med 2018;31:958-66. [PMID: 28277906 DOI: 10.1080/14767058.2017.1301927] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
36 Jensen EA, Wright CJ. Bronchopulmonary Dysplasia: The Ongoing Search for One Definition to Rule Them All. The Journal of Pediatrics 2018;197:8-10. [DOI: 10.1016/j.jpeds.2018.02.047] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
37 van der Graaf M, Rojer LA, Helbing W, Reiss I, Etnel JRG, Bartelds B. EXPRESS: Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis. Pulm Circ 2019;:2045894019837875. [PMID: 30803328 DOI: 10.1177/2045894019837875] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
38 Abman SH, Conway SJ. Developmental determinants and changing patterns of respiratory outcomes after preterm birth. Birth Defects Res A Clin Mol Teratol 2014;100:127-33. [PMID: 24659395 DOI: 10.1002/bdra.23242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
39 Sunday ME. Oxygen, gastrin-releasing Peptide, and pediatric lung disease: life in the balance. Front Pediatr 2014;2:72. [PMID: 25101250 DOI: 10.3389/fped.2014.00072] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
40 Costello JM, Kim F, Polin R, Krishnamurthy G. Double Jeopardy: Prematurity and Congenital Heart Disease-What's Known and Why It's Important. World J Pediatr Congenit Heart Surg 2022;13:65-71. [PMID: 34919482 DOI: 10.1177/21501351211062606] [Reference Citation Analysis]
41 Cai H, Jiang L, Liu Y, Shen T, Yang Z, Wang S, Ma Y. Development and verification of a risk prediction model for bronchopulmonary dysplasia in very low birth weight infants. Transl Pediatr 2021;10:2533-43. [PMID: 34765477 DOI: 10.21037/tp-21-445] [Reference Citation Analysis]
42 Sun YH, Yuan L, Du Y, Zhou JG, Lin SB, Zhang R, Dong Y, Chen C. Characterization of lung ultrasound imaging in preterm infants with bronchopulmonary dysplasia. Clin Hemorheol Microcirc 2021. [PMID: 33935069 DOI: 10.3233/CH-211132] [Reference Citation Analysis]
43 Collaco JM, Dadlani GH, Nies MK, Leshko J, Everett AD, McGrath-Morrow SA. Risk Factors and Clinical Outcomes in Preterm Infants with Pulmonary Hypertension. PLoS One 2016;11:e0163904. [PMID: 27716811 DOI: 10.1371/journal.pone.0163904] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
44 Jensen EA, Panitch H, Feng R, Moore PE, Schmidt B. Interobserver Reliability of the Respiratory Physical Examination in Premature Infants: A Multicenter Study. J Pediatr 2016;178:87-92. [PMID: 27567413 DOI: 10.1016/j.jpeds.2016.07.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
45 Mir IN, Leon R, Chalak LF. Placental origins of neonatal diseases: toward a precision medicine approach. Pediatr Res 2021;89:377-83. [PMID: 33288874 DOI: 10.1038/s41390-020-01293-6] [Reference Citation Analysis]
46 Shah D, Sandhu K, Das P, Bhandari V. Adiponectin ameliorates hyperoxia-induced lung endothelial dysfunction and promotes angiogenesis in neonatal mice. Pediatr Res 2021. [PMID: 33767374 DOI: 10.1038/s41390-021-01442-5] [Reference Citation Analysis]
47 Taylor SK, Sakurai R, Sakurai T, Rehan VK. Inhaled Vitamin D: A Novel Strategy to Enhance Neonatal Lung Maturation. Lung 2016;194:931-43. [PMID: 27614961 DOI: 10.1007/s00408-016-9939-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
48 Behnke J, Lemyre B, Czernik C, Zimmer KP, Ehrhardt H, Waitz M. Non-Invasive Ventilation in Neonatology. Dtsch Arztebl Int 2019;116:177-83. [PMID: 31014448 DOI: 10.3238/arztebl.2019.0177] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
49 Sheehan S, Baer G, Romine M, Hudson L, Lim R, Papadopoulos E, Campbell M, Daniel G, McCune S. Advancing Therapeutic Development for Pulmonary Morbidities Associated with Preterm Birth. Ther Innov Regul Sci 2020;54:1312-8. [PMID: 33258093 DOI: 10.1007/s43441-020-00153-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Shin J, Lee JA, Oh S, Lee EH, Choi BM. Conservative Treatment Without Any Intervention Compared With Other Therapeutic Strategies for Symptomatic Patent Ductus Arteriosus in Extremely Preterm Infants: A Nationwide Cohort Study in Korea. Front Pediatr 2021;9:729329. [PMID: 34692607 DOI: 10.3389/fped.2021.729329] [Reference Citation Analysis]
51 Perrone S, Santacroce A, Longini M, Proietti F, Bazzini F, Buonocore G. The Free Radical Diseases of Prematurity: From Cellular Mechanisms to Bedside. Oxid Med Cell Longev 2018;2018:7483062. [PMID: 30140369 DOI: 10.1155/2018/7483062] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
52 de Oliveira Peixoto FA, Costa PSS. Reviewing the use of corticosteroids in bronchopulmonary dysplasia. Jornal de Pediatria 2016;92:122-8. [DOI: 10.1016/j.jped.2015.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Muehlbacher T, Bassler D, Bryant MB. Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants. Children (Basel) 2021;8:298. [PMID: 33924638 DOI: 10.3390/children8040298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Sakaria RP, Dhanireddy R. Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence? Front Pediatr 2022;10:820259. [DOI: 10.3389/fped.2022.820259] [Reference Citation Analysis]
55 Rysavy MA, Li L, Tyson JE, Jensen EA, Das A, Ambalavanan N, Laughon MM, Greenberg RG, Patel RM, Pedroza C, Bell EF; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial. J Pediatr 2021;236:78-85.e5. [PMID: 34004189 DOI: 10.1016/j.jpeds.2021.05.022] [Reference Citation Analysis]
56 Resch B, Kurath-Koller S, Eibisberger M, Zenz W. Prematurity and the burden of influenza and respiratory syncytial virus disease. World J Pediatr 2016;12:8-18. [PMID: 26582294 DOI: 10.1007/s12519-015-0055-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
57 Villamor-Martínez E, Pierro M, Cavallaro G, Mosca F, Villamor E. Mother's Own Milk and Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis. Front Pediatr 2019;7:224. [PMID: 31275904 DOI: 10.3389/fped.2019.00224] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
58 Collins JJP, Tibboel D, de Kleer IM, Reiss IKM, Rottier RJ. The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment. Front Med (Lausanne) 2017;4:61. [PMID: 28589122 DOI: 10.3389/fmed.2017.00061] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
59 Witkowski SM, de Castro EM, Nagashima S, Martins APC, Okamoto CT, Nakata GTM, Collete M, Machado-Souza C, de Noronha L. Analysis of interleukins 6, 8, 10 and 17 in the lungs of premature neonates with bronchopulmonary dysplasia. Cytokine 2020;131:155118. [PMID: 32403004 DOI: 10.1016/j.cyto.2020.155118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
60 Rodriguez-Martinez CE, Acuña-Cordero R, Sossa-Briceño MP. Predictors of prolonged length of hospital stay or readmissions for acute viral lower respiratory tract infections among infants with a history of bronchopulmonary dysplasia. J Med Virol 2018;90:405-11. [PMID: 28975628 DOI: 10.1002/jmv.24962] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
61 Chavez L, Meguro J, Chen S, de Paiva VN, Zambrano R, Eterno JM, Kumar R, Duncan MR, Benny M, Young KC, Dietrich WD, Brambilla R, Wu S, Schmidt AF. Circulating extracellular vesicles activate the pyroptosis pathway in the brain following ventilation-induced lung injury. J Neuroinflammation 2021;18:310. [PMID: 34965880 DOI: 10.1186/s12974-021-02364-z] [Reference Citation Analysis]
62 Ralphe JL, Silva SG, Dail RB, Brandon DH. Body temperature instability and respiratory morbidity in the very low birth weight infant: a multiple case, intensive longitudinal study. BMC Pediatr 2020;20:485. [PMID: 33081746 DOI: 10.1186/s12887-020-02351-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Mowitz ME, Ayyagari R, Gao W, Zhao J, Mangili A, Sarda SP. Health Care Burden of Bronchopulmonary Dysplasia Among Extremely Preterm Infants. Front Pediatr 2019;7:510. [PMID: 31921723 DOI: 10.3389/fped.2019.00510] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
64 Ansems SM, Kirpalani H, Mercer-Rosa L, Wang Y, Hopper RK, Fraga MV, Jensen EA. Patent Ductus Arteriosus and the Effects of Its Late Closure in Preterm Infants with Severe Bronchopulmonary Dysplasia. Neonatology 2019;116:236-43. [PMID: 31269508 DOI: 10.1159/000500269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Chen Y, Zhang D, Li Y, Yan A, Wang X, Hu X, Shi H, Du Y, Zhang W. Risk Factors and Outcomes of Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia: A Meta-Analysis. Front Pediatr 2021;9:695610. [PMID: 34249820 DOI: 10.3389/fped.2021.695610] [Reference Citation Analysis]
66 Hasan SU, Lodha AK, Yusuf K, Dalgleish S. Physiological Basis of Neonatal Aerodigestive Difficulties in Chronic Lung Disease. Clin Perinatol 2020;47:277-99. [PMID: 32439112 DOI: 10.1016/j.clp.2020.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Shrestha AK, Bettini ML, Menon RT, Gopal VYN, Huang S, Edwards DP, Pammi M, Barrios R, Shivanna B. Consequences of early postnatal lipopolysaccharide exposure on developing lungs in mice. Am J Physiol Lung Cell Mol Physiol 2019;316:L229-44. [PMID: 30307313 DOI: 10.1152/ajplung.00560.2017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
68 Sahni M, Bhandari V. Patho-mechanisms of the origins of bronchopulmonary dysplasia. Mol Cell Pediatr 2021;8:21. [PMID: 34894313 DOI: 10.1186/s40348-021-00129-5] [Reference Citation Analysis]
69 Grant GJ, Mimche PN, Paine R 3rd, Liou TG, Qian WJ, Helms MN. Enhanced epithelial sodium channel activity in neonatal Scnn1b mouse lung attenuates high oxygen-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2021;321:L29-41. [PMID: 33949206 DOI: 10.1152/ajplung.00538.2020] [Reference Citation Analysis]
70 Boel L, Banerjee S, Chakraborty M. Postnatal steroids in extreme preterm infants: Intra-tracheal instillation using surfactant as a vehicle. Paediatr Respir Rev 2018;25:78-84. [PMID: 28651937 DOI: 10.1016/j.prrv.2017.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
71 Schmiedl A, Wagener I, Jungen M, von Hörsten S, Stephan M. Lung development and immune status under chronic LPS exposure in rat pups with and without CD26/DPP4 deficiency. Cell Tissue Res 2021;386:617-36. [PMID: 34606000 DOI: 10.1007/s00441-021-03522-8] [Reference Citation Analysis]
72 Kim F, Bateman DA, Goldshtrom N, Sahni R, Wung JT, Wallman-Stokes A. Revisiting the definition of bronchopulmonary dysplasia in premature infants at a single center quaternary neonatal intensive care unit. J Perinatol 2021;41:756-63. [PMID: 33649435 DOI: 10.1038/s41372-021-00980-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Szpecht D, Gadzinowski J, Nowak I, Cygan D, Seremak-Mrozikiewicz A, Kurzawińska G, Madajczak D, Drews K, Szymankiewicz M. The significance of IL-1β +3953C>T, IL-6 -174G>C and -596G>A, TNF-α -308G>A gene polymorphisms and 86 bp variable number tandem repeat polymorphism of IL-1RN in bronchopulmonary dysplasia in infants born before 32 weeks of gestation. Cent Eur J Immunol 2017;42:287-93. [PMID: 29204094 DOI: 10.5114/ceji.2017.67000] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
74 Plosa EJ, Benjamin JT. rhIGF-1 Therapy: A Silver Bullet for Bronchopulmonary Dysplasia Prevention? Am J Respir Crit Care Med 2020;201:1032-3. [PMID: 32109132 DOI: 10.1164/rccm.202002-0287ED] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Rojas P, Friaza V, García E, de la Horra C, Vargas SL, Calderón EJ, Pavón A. Early Acquisition of Pneumocystis jirovecii Colonization and Potential Association With Respiratory Distress Syndrome in Preterm Newborn Infants. Clin Infect Dis 2017;65:976-81. [PMID: 28520902 DOI: 10.1093/cid/cix454] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
76 Lai PY, Jing X, Michalkiewicz T, Entringer B, Ke X, Majnik A, Kriegel AJ, Liu P, Lane RH, Konduri GG. Adverse early-life environment impairs postnatal lung development in mice. Physiol Genomics 2019;51:462-70. [PMID: 31373541 DOI: 10.1152/physiolgenomics.00016.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Yoder LM, Higano NS, Schapiro AH, Fleck RJ, Hysinger EB, Bates AJ, Kingma PS, Merhar SL, Fain SB, Woods JC. Elevated lung volumes in neonates with bronchopulmonary dysplasia measured via MRI. Pediatr Pulmonol 2019;54:1311-8. [PMID: 31134768 DOI: 10.1002/ppul.24378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
78 D'Agrosa C, Cai CL, Siddiqui F, Deslouches K, Wadowski S, Aranda JV, Beharry KD. Comparison of coenzyme Q10 or fish oil for prevention of intermittent hypoxia-induced oxidative injury in neonatal rat lungs. Respir Res 2021;22:196. [PMID: 34225702 DOI: 10.1186/s12931-021-01786-w] [Reference Citation Analysis]
79 Siffel C, Kistler KD, Lewis JFM, Sarda SP. Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern Fetal Neonatal Med 2021;34:1721-31. [PMID: 31397199 DOI: 10.1080/14767058.2019.1646240] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
80 Cheon IS, Son YM, Jiang L, Goplen NP, Kaplan MH, Limper AH, Kita H, Paczesny S, Prakash YS, Tepper R, Ahlfeld SK, Sun J. Neonatal hyperoxia promotes asthma-like features through IL-33-dependent ILC2 responses. J Allergy Clin Immunol 2018;142:1100-12. [PMID: 29253513 DOI: 10.1016/j.jaci.2017.11.025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
81 Bhandari V. Drug therapy trials for the prevention of bronchopulmonary dysplasia: current and future targets. Front Pediatr 2014;2:76. [PMID: 25121076 DOI: 10.3389/fped.2014.00076] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
82 Ricci F, Catozzi C, Ravanetti F, Murgia X, D'Aló F, Macchidani N, Sgarbi E, Di Lallo V, Saccani F, Pertile M, Cacchioli A, Catinella S, Villetti G, Civelli M, Amadei F, Stellari FF, Pioselli B, Salomone F. In vitro and in vivo characterization of poractant alfa supplemented with budesonide for safe and effective intratracheal administration. Pediatr Res 2017;82:1056-63. [PMID: 28723887 DOI: 10.1038/pr.2017.171] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
83 Kallio M, Koskela U, Peltoniemi O, Kontiokari T, Pokka T, Suo-palosaari M, Saarela T. Neurally adjusted ventilatory assist (NAVA) in preterm newborn infants with respiratory distress syndrome—a randomized controlled trial. Eur J Pediatr 2016;175:1175-83. [DOI: 10.1007/s00431-016-2758-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
84 Cristea AI, Ren CL, Amin R, Eldredge LC, Levin JC, Majmudar PP, May AE, Rose RS, Tracy MC, Watters KF, Allen J, Austin ED, Cataletto ME, Collaco JM, Fleck RJ, Gelfand A, Hayes D Jr, Jones MH, Kun SS, Mandell EW, McGrath-Morrow SA, Panitch HB, Popatia R, Rhein LM, Teper A, Woods JC, Iyer N, Baker CD. Outpatient Respiratory Management of Infants, Children, and Adolescents with Post-Prematurity Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2021;204:e115-33. [PMID: 34908518 DOI: 10.1164/rccm.202110-2269ST] [Reference Citation Analysis]
85 Sisman Y, Buchvald FF, Ring AM, Wassilew K, Nielsen KG. Long-Term Lung Function and Exercise Capacity in Postinfectious chILD. Pediatr Allergy Immunol Pulmonol 2019;32:4-11. [PMID: 31032143 DOI: 10.1089/ped.2018.0973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Tamai K, Nishihara M, Hirata K, Shiraishi J, Hirano S, Fujimura M, Yano S, Kanazawa T, Kitajima H. Physical fitness of non-disabled school-aged children born with extremely low birth weights. Early Human Development 2019;128:6-11. [DOI: 10.1016/j.earlhumdev.2018.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
87 Davidson LM, Berkelhamer SK. Bronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary Outcomes. J Clin Med. 2017;6:4. [PMID: 28067830 DOI: 10.3390/jcm6010004] [Cited by in Crossref: 128] [Cited by in F6Publishing: 106] [Article Influence: 25.6] [Reference Citation Analysis]
88 Hanita T, Matsuda T, Saito M, Kitanishi R, Cho K, Harding R, Kobayashi Y. Potential Role of Prenatal Inflammation in the Impairment of Lung Development Following Mechanical Ventilation of Preterm Lambs. Reprod Sci 2017;24:478-87. [DOI: 10.1177/1933719116660846] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
89 Lehtinen A, Korhonen P, Hyödynmaa E, Koivisto AM, Peltola T, Hämäläinen M, Moilanen E, Tammela O. Adipokines played a limited role in predicting temporary growth differences between very low birthweight infants with and without bronchopulmonary dysplasia. Acta Paediatr 2017;106:1583-8. [PMID: 28639282 DOI: 10.1111/apa.13942] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
90 Abraha HY, Lanctôt KL, Paes B. Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention. Expert Rev Respir Med 2015;9:779-99. [PMID: 26457970 DOI: 10.1586/17476348.2015.1098536] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
91 Zhong Q, Wang L, Qi Z, Cao J, Liang K, Zhang C, Duan J. Long Non-coding RNA TUG1 Modulates Expression of Elastin to Relieve Bronchopulmonary Dysplasia via Sponging miR-29a-3p. Front Pediatr 2020;8:573099. [PMID: 33194901 DOI: 10.3389/fped.2020.573099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Dani C. Nasal Continuous Positive Airway Pressure and High-Flow Nasal Cannula Today. Clin Perinatol 2021;48:711-24. [PMID: 34774205 DOI: 10.1016/j.clp.2021.07.002] [Reference Citation Analysis]
93 Oji-Mmuo CN, Siddaiah R, Montes DT, Pham MA, Spear D, Donnelly A, Fuentes N, Imamura-Kawasawa Y, Howrylak JA, Thomas NJ, Silveyra P. Tracheal aspirate transcriptomic and miRNA signatures of extreme premature birth with bronchopulmonary dysplasia. J Perinatol 2021;41:551-61. [PMID: 33177681 DOI: 10.1038/s41372-020-00868-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Shaffer ML, Baud O, Lacaze-Masmonteil T, Peltoniemi OM, Bonsante F, Watterberg KL. Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis. J Pediatr 2019;207:136-142.e5. [PMID: 30416014 DOI: 10.1016/j.jpeds.2018.10.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
95 Kim HR, Jung YH, Kim BI, Kim SY, Choi CW. Differences in Comorbidities and Clinical Burden of Severe Bronchopulmonary Dysplasia Based on Disease Severity. Front Pediatr 2021;9:664033. [PMID: 34277516 DOI: 10.3389/fped.2021.664033] [Reference Citation Analysis]
96 Dassios T, Williams EE, Hickey A, Greenough A. Duration of mechanical ventilation and prediction of bronchopulmonary dysplasia and home oxygen in extremely preterm infants. Acta Paediatr 2021;110:2052-8. [PMID: 33555069 DOI: 10.1111/apa.15801] [Reference Citation Analysis]
97 Xu Q, Yu J, Liu D, Tan Q, He Y. The Airway Microbiome and Metabolome in Preterm Infants: Potential Biomarkers of Bronchopulmonary Dysplasia. Front Pediatr 2022;10:862157. [DOI: 10.3389/fped.2022.862157] [Reference Citation Analysis]
98 Méndez-Abad P, Zafra-Rodríguez P, Lubián-López S, Benavente-Fernández I. Myocardial Function Maturation in Very-Low-Birth-Weight Infants and Development of Bronchopulmonary Dysplasia. Front Pediatr 2019;7:556. [PMID: 32010652 DOI: 10.3389/fped.2019.00556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Abreu-pereira S, Pinto-lopes R, Flôr-de-lima F, Rocha G, Guimarães H. Ventilatory practices in extremely low birth weight infants in a level III neonatal intensive care unit. Pulmonology 2018;24:337-44. [DOI: 10.1016/j.pulmoe.2018.02.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
100 Cassiano RGM, Gaspardo CM, Faciroli RADD, Martinez FE, Linhares MBM. Temperament and behavior in toddlers born preterm with related clinical problems. Early Human Development 2017;112:1-8. [DOI: 10.1016/j.earlhumdev.2017.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
101 Butler B, De Dios R, Nguyen L, McKenna S, Ghosh S, Wright CJ. Developmentally Regulated Innate Immune NFκB Signaling Mediates IL-1α Expression in the Perinatal Murine Lung. Front Immunol 2019;10:1555. [PMID: 31354715 DOI: 10.3389/fimmu.2019.01555] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
102 Higgins RD, Jobe AH, Koso-Thomas M, Bancalari E, Viscardi RM, Hartert TV, Ryan RM, Kallapur SG, Steinhorn RH, Konduri GG, Davis SD, Thebaud B, Clyman RI, Collaco JM, Martin CR, Woods JC, Finer NN, Raju TNK. Bronchopulmonary Dysplasia: Executive Summary of a Workshop. J Pediatr 2018;197:300-8. [PMID: 29551318 DOI: 10.1016/j.jpeds.2018.01.043] [Cited by in Crossref: 199] [Cited by in F6Publishing: 158] [Article Influence: 49.8] [Reference Citation Analysis]
103 Bauer SE, Schneider L, Lynch SK, Malleske DT, Shepherd EG, Nelin LD. Factors Associated with Neurodevelopmental Impairment in Bronchopulmonary Dysplasia. The Journal of Pediatrics 2020;218:22-27.e2. [DOI: 10.1016/j.jpeds.2019.11.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
104 Thome UH, Genzel-Boroviczeny O, Bohnhorst B, Schmid M, Fuchs H, Rohde O, Avenarius S, Topf HG, Zimmermann A, Faas D, Timme K, Kleinlein B, Buxmann H, Schenk W, Segerer H, Teig N, Gebauer C, Hentschel R, Heckmann M, Schlösser R, Peters J, Rossi R, Rascher W, Böttger R, Seidenberg J, Hansen G, Zernickel M, Alzen G, Dreyhaupt J, Muche R, Hummler HD; PHELBI Study Group. Permissive hypercapnia in extremely low birthweight infants (PHELBI): a randomised controlled multicentre trial. Lancet Respir Med 2015;3:534-43. [PMID: 26088180 DOI: 10.1016/S2213-2600(15)00204-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 19] [Article Influence: 6.4] [Reference Citation Analysis]
105 Tan S, Szatkowski L, Moreton W, Fiaschi L, Mckeever T, Gibson J, Sharkey D. Early childhood respiratory morbidity and antibiotic use in ex-preterm infants: a primary care population-based cohort study. Eur Respir J 2020;56:2000202. [DOI: 10.1183/13993003.00202-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Silveyra P, Fuentes N, Rodriguez Bauza DE. Sex and Gender Differences in Lung Disease. Adv Exp Med Biol 2021;1304:227-58. [PMID: 34019273 DOI: 10.1007/978-3-030-68748-9_14] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
107 Wallström L, Sjöberg A, Sindelar R. Early volume targeted ventilation in preterm infants born at 22-25 weeks of gestational age. Pediatr Pulmonol 2021;56:1000-7. [PMID: 33611849 DOI: 10.1002/ppul.25271] [Reference Citation Analysis]
108 Rozycki HJ. Potential contribution of type I alveolar epithelial cells to chronic neonatal lung disease. Front Pediatr 2014;2:45. [PMID: 24904906 DOI: 10.3389/fped.2014.00045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
109 Kalikkot Thekkeveedu R, Guaman MC, Shivanna B. Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology. Respir Med 2017;132:170-7. [PMID: 29229093 DOI: 10.1016/j.rmed.2017.10.014] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 17.4] [Reference Citation Analysis]
110 Méndez-abad P, Zafra-rodríguez P, Lubián-lópez S, Benavente-fernández I. NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants. Eur J Pediatr 2019;178:755-61. [DOI: 10.1007/s00431-019-03347-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
111 Bhandari V, Gruen JR. What is the basis for a genetic approach in neonatal disorders? Semin Perinatol 2015;39:568-73. [PMID: 26471062 DOI: 10.1053/j.semperi.2015.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
112 Tracy MK, Berkelhamer SK. Bronchopulmonary Dysplasia and Pulmonary Outcomes of Prematurity. Pediatr Ann 2019;48. [DOI: 10.3928/19382359-20190325-03] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
113 Panneel L, Malarvannan G, Jorens PG, Covaci A, Mulder A. Plasticizers in the neonatal intensive care unit: A review on exposure sources and health hazards. Critical Reviews in Environmental Science and Technology. [DOI: 10.1080/10643389.2021.1970455] [Reference Citation Analysis]
114 Mowitz ME, Mangili A, Han L, Ayyagari R, Gao W, Wang J, Zhao J, Sarda SP. Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia. Expert Review of Pharmacoeconomics & Outcomes Research. [DOI: 10.1080/14737167.2021.1848554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
115 Appuhn SV, Siebert S, Myti D, Wrede C, Surate Solaligue DE, Pérez-Bravo D, Brandenberger C, Schipke J, Morty RE, Grothausmann R, Mühlfeld C. Capillary Changes Precede Disordered Alveolarization in a Mouse Model of Bronchopulmonary Dysplasia. Am J Respir Cell Mol Biol 2021;65:81-91. [PMID: 33784484 DOI: 10.1165/rcmb.2021-0004OC] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
116 Sharma A, Xin Y, Chen X, Sood BG. Early prediction of moderate to severe bronchopulmonary dysplasia in extremely premature infants. Pediatr Neonatol 2020;61:290-9. [PMID: 32217025 DOI: 10.1016/j.pedneo.2019.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
117 Willis KA, Siefker DT, Aziz MM, White CT, Mussarat N, Gomes CK, Bajwa A, Pierre JF, Cormier SA, Talati AJ. Perinatal maternal antibiotic exposure augments lung injury in offspring in experimental bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2020;318:L407-18. [PMID: 31644311 DOI: 10.1152/ajplung.00561.2018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
118 Teoh S, Bhat R, Greenough A, Dassios T. Predicting the duration of supplemental home oxygen in prematurely-born infants at discharge from neonatal care. Early Hum Dev 2021;157:105353. [PMID: 33836487 DOI: 10.1016/j.earlhumdev.2021.105353] [Reference Citation Analysis]
119 Ortiz LE, McGrath-Morrow SA, Sterni LM, Collaco JM. Sleep disordered breathing in bronchopulmonary dysplasia. Pediatr Pulmonol 2017;52:1583-91. [PMID: 29064170 DOI: 10.1002/ppul.23769] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
120 Ruiz-Camp J, Rodríguez-Castillo JA, Herold S, Mayer K, Vadász I, Tallquist MD, Seeger W, Ahlbrecht K, Morty RE. Tamoxifen dosing for Cre-mediated recombination in experimental bronchopulmonary dysplasia. Transgenic Res 2017;26:165-70. [PMID: 27730498 DOI: 10.1007/s11248-016-9987-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
121 Naeem B, Ayub A, Aly AM, Malloy MH, Okorodudu AO, Jain SK. Urinary NT-proBNP as a potential noninvasive biomarker for screening of pulmonary hypertension in preterm infants: a pilot study. J Perinatol 2020;40:628-32. [PMID: 31911650 DOI: 10.1038/s41372-019-0581-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
122 Sucasas Alonso A, Pértega Diaz S, Sáez Soto R, Avila-alvarez A. Epidemiology and risk factors for bronchopulmonary dysplasia in preterm infants born at or less than 32 weeks of gestation. Anales de Pediatría (English Edition) 2022. [DOI: 10.1016/j.anpede.2021.03.006] [Reference Citation Analysis]
123 Gallacher DJ, Kotecha S. Respiratory Microbiome of New-Born Infants. Front Pediatr. 2016;4:10. [PMID: 26942168 DOI: 10.3389/fped.2016.00010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
124 Jimenez J, Richter J, Toelen J, Deprest J. Prenatal interventions to prevent bronchopulmonary dysplasia in animal models: a systematic review. J Matern Fetal Neonatal Med 2016;29:2555-62. [PMID: 26456571 DOI: 10.3109/14767058.2015.1094789] [Reference Citation Analysis]
125 Mavunda K, Jiang X, Ambrose CS. Prevalence and clinical characteristics of perinatal chronic lung disease by infant gestational age. J Neonatal Perinatal Med 2021;14:43-51. [PMID: 32474477 DOI: 10.3233/NPM-200412] [Reference Citation Analysis]
126 Sucre JM, Wilkinson D, Vijayaraj P, Paul M, Dunn B, Alva-Ornelas JA, Gomperts BN. A three-dimensional human model of the fibroblast activation that accompanies bronchopulmonary dysplasia identifies Notch-mediated pathophysiology. Am J Physiol Lung Cell Mol Physiol 2016;310:L889-98. [PMID: 26968771 DOI: 10.1152/ajplung.00446.2015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
127 Potsiurko S, Dobryanskyy D, Sekretar L. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial. BMC Pediatr 2021;21:286. [PMID: 34147090 DOI: 10.1186/s12887-021-02750-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Salaets T, Richter J, Brady P, Jimenez J, Nagatomo T, Deprest J, Toelen J. Transcriptome Analysis of the Preterm Rabbit Lung after Seven Days of Hyperoxic Exposure. PLoS One 2015;10:e0136569. [PMID: 26317699 DOI: 10.1371/journal.pone.0136569] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
129 Faggiano S, Ronda L, Raboni S, Sartor F, Cavatorta V, Sgarbi E, Caivano G, Pertile M, Mozzarelli A. Phospholipid components of the synthetic pulmonary surfactant CHF5633 probed by fluorescence spectroscopy. Int J Pharm 2018;553:290-7. [PMID: 30366070 DOI: 10.1016/j.ijpharm.2018.10.045] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
130 Avila-Alvarez A, Zozaya C, Pértega-Diaz S, Sanchez-Luna M, Iriondo-Sanz M, Elorza MD, García-Muñoz Rodrigo F; Spanish Neonatal Network SEN1500. Temporal trends in respiratory care and bronchopulmonary dysplasia in very preterm infants over a 10-year period in Spain. Arch Dis Child Fetal Neonatal Ed 2021:fetalneonatal-2021-322402. [PMID: 34321246 DOI: 10.1136/archdischild-2021-322402] [Reference Citation Analysis]
131 Zhang H, Fox WW. Management of the Infant with Bronchopulmonary Dysplasia. Assisted Ventilation of the Neonate. Elsevier; 2017. pp. 380-390.e3. [DOI: 10.1016/b978-0-323-39006-4.00035-1] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
132 Montigaud Y, Périnel S, Dubus JC, Leclerc L, Suau M, Goy C, Clotagatide A, Prévôt N, Pourchez J. Development of an ex vivo respiratory pediatric model of bronchopulmonary dysplasia for aerosol deposition studies. Sci Rep 2019;9:5720. [PMID: 30952897 DOI: 10.1038/s41598-019-42103-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
133 Qing C, Ziyun L, Xuefei Y, Xinyi Z, Xindong X, Jianhua F. Protective Effects of 18β-Glycyrrhetinic Acid on Neonatal Rats with Hyperoxia Exposure. Inflammation 2022. [PMID: 34989920 DOI: 10.1007/s10753-021-01616-7] [Reference Citation Analysis]
134 Jung E, Lee BS. Late-Onset Sepsis as a Risk Factor for Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants: A Nationwide Cohort Study. Sci Rep 2019;9:15448. [PMID: 31664055 DOI: 10.1038/s41598-019-51617-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
135 Jhaveri Sanghvi U, Wright CJ, Hernandez TL. Pulmonary Resilience: Moderating the Association between Oxygen Exposure and Pulmonary Outcomes in Extremely Preterm Newborns. Neonatology 2022;:1-10. [PMID: 35551136 DOI: 10.1159/000524438] [Reference Citation Analysis]
136 Dietz RM, Wright CJ. Oxidative stress diseases unique to the perinatal period: A window into the developing innate immune response. Am J Reprod Immunol 2018;79:e12787. [PMID: 29194835 DOI: 10.1111/aji.12787] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
137 McKenna S, Butler B, Jatana L, Ghosh S, Wright CJ. Inhibition of IκBβ/NFκB signaling prevents LPS-induced IL1β expression without increasing apoptosis in the developing mouse lung. Pediatr Res 2017;82:1064-72. [PMID: 28753596 DOI: 10.1038/pr.2017.182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
138 Gallacher DJ, Hart K, Kotecha S. Common respiratory conditions of the newborn. Breathe (Sheff) 2016;12:30-42. [PMID: 27064402 DOI: 10.1183/20734735.000716] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
139 Mueller M, Wolfs TG, Schoeberlein A, Gavilanes AW, Surbek D, Kramer BW. Mesenchymal stem/stromal cells-a key mediator for regeneration after perinatal morbidity? Mol Cell Pediatr 2016;3:6. [PMID: 26869264 DOI: 10.1186/s40348-016-0034-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
140 Gomez Pomar E, Concina VA, Samide A, Westgate PM, Bada HS. Bronchopulmonary Dysplasia: Comparison Between the Two Most Used Diagnostic Criteria. Front Pediatr 2018;6:397. [PMID: 30619792 DOI: 10.3389/fped.2018.00397] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
141 Qing C, Xinyi Z, Xuefei Y, Xindong X, Jianhua F. The Specific Connexin 43-Inhibiting Peptide Gap26 Improved Alveolar Development of Neonatal Rats With Hyperoxia Exposure. Front Pharmacol 2021;12:587267. [PMID: 34290603 DOI: 10.3389/fphar.2021.587267] [Reference Citation Analysis]
142 Dassios T, Williams EE, Hickey A, Bunce C, Greenough A. Bronchopulmonary dysplasia and postnatal growth following extremely preterm birth. Arch Dis Child Fetal Neonatal Ed 2021;106:386-91. [PMID: 33334820 DOI: 10.1136/archdischild-2020-320816] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Linafelter A, Cuna A, Liu C, Quigley A, Truog WE, Sampath V, Oschman A. Extended course of prednisolone in infants with severe bronchopulmonary dysplasia. Early Hum Dev 2019;136:1-6. [PMID: 31265946 DOI: 10.1016/j.earlhumdev.2019.06.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
144 Salaets T, Aertgeerts M, Gie A, Vignero J, de Winter D, Regin Y, Jimenez J, Vande Velde G, Allegaert K, Deprest J, Toelen J. Preterm birth impairs postnatal lung development in the neonatal rabbit model. Respir Res 2020;21:59. [PMID: 32085773 DOI: 10.1186/s12931-020-1321-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
145 Guo WL, Eli IM, Ripoll JG, Baker SE, Shepherd JRA, Wiggins CC, Welch BT, Joyner MJ, Dominelli PB. Bronchopulmonary dysplasia patients have preserved CT-measured central airway luminal area. Respir Med 2020;170:106071. [PMID: 32843156 DOI: 10.1016/j.rmed.2020.106071] [Reference Citation Analysis]
146 Choi YB, Lee J, Park J, Jun YH. Impact of Prolonged Mechanical Ventilation in Very Low Birth Weight Infants: Results From a National Cohort Study. J Pediatr 2018;194:34-39.e3. [PMID: 29198532 DOI: 10.1016/j.jpeds.2017.10.042] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]